Gunze aims to commercialize regenerative blood vessels

Gunze aims to commercialize regenerative blood vessels

AYABE, Japan - Masakazu Suzuki, director of Gunze Ltd.'s quality of life research center, shows a tube for producing fiber-engineered blood vessels during a press tour of the facility in Ayabe, Kyoto Prefecture, western Japan, on Dec. 3, 2014. The apparel company aims to commercialize the world's first regenerative blood vessels in the United States by 2016. (Kyodo)

  • Product Code
  • ILEA000338972
  • Registered date
  • 2014/12/08 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1292 × 1893 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 244.80(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    New whaling factory ship

    New whaling factory ship

    Hideki Tokoro, president of commercial whaling operator Kyodo Senpaku Co., meets the press in Shimonoseki, western Japan, on March 29, 2024, after Kangei Maru, the world's only whaling factory ship, was delivered to his company earlier in the day, following the retirement of its predecessor, Nisshin Maru, in November 2023.
      KM Biologics begins development of vaccine for novel coronavirus

      KM Biologics begins development of vaccine for novel coronavirus

      KM Biologics (Kita Ward, Kumamoto City) has started to develop a vaccine for a new coronavirus infection. At a press conference held on April 25, President Nagasato said, "Our strength lies in the fact that we have skilled technicians and facilities from our days at the Research Institute for Chemotherapy and Serotherapy (KAKETSUKEN). As a member of the Meiji Group, we will do our utmost to expand this business. The new drug will be developed jointly with the National Institute of Infectious Diseases, the Institute of Medical Science of the University of Tokyo, and the National Institute of Biomedical Innovation, Health and Nutrition. The company will consider using its Kikuchi Research Center in Kikuchi City, Kumamoto Prefecture, and its Koshi Plant in Koshi City, Kumamoto Prefecture, which are capable of producing vaccines for 57 million new influenza cases. (Photo taken on May 25, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
        External view of Shimizu Corporation's Technical Research Center

        External view of Shimizu Corporation's Technical Research Center

        Buildings and facilities = July 19, 2019, Koto-ku, Tokyo; Credit: The Nikkan Kogyo Shimbun / Kyodo News Images
          External view of Shimizu Corporation's Technical Research Center

          External view of Shimizu Corporation's Technical Research Center

          Buildings and facilities = July 19, 2019, Koto-ku, Tokyo; Credit: The Nikkan Kogyo Shimbun / Kyodo News Images
            External view of Shimizu Corporation's Technical Research Center

            External view of Shimizu Corporation's Technical Research Center

            Buildings and facilities = July 19, 2019, Koto-ku, Tokyo; Credit: The Nikkan Kogyo Shimbun / Kyodo News Images
              External view of Shimizu Corporation's Technical Research Center

              External view of Shimizu Corporation's Technical Research Center

              Buildings and facilities = July 19, 2019, Koto-ku, Tokyo; Credit: The Nikkan Kogyo Shimbun / Kyodo News Images
                External view of Shimizu Corporation's Technical Research Center

                External view of Shimizu Corporation's Technical Research Center

                Buildings and facilities = July 19, 2019, Koto-ku, Tokyo; Credit: The Nikkan Kogyo Shimbun / Kyodo News Images
                  Research launched on pregnancy-induced diseases

                  Research launched on pregnancy-induced diseases

                  TOKYO, Japan - Narumi Umeda (R), director of NTT Docomo Inc.'s Research Laboratories, poses with Nobuo Yaegashi, deputy executive director of Tohoku Medical Megabank Organization, at a press conference in Tokyo on Nov. 19, 2014, announcing the launch of a joint project to establish mobile monitoring methods for the prevention and early detection of pregnancy-induced diseases. (Kyodo)
                    Tokyo Motor Show opens with focus on cute and sports cars

                    Tokyo Motor Show opens with focus on cute and sports cars

                    CHIBA, Japan - Toyota Motor Corp. President Katsuaki Watanabe drives the company's roofless i-Real robotic single-seat vehicle during a press preview of the 40th Tokyo Motor Show at Makuhari Messe convention center in Chiba on Oct. 24. The show, which will be opened to the public from Oct. 27 to Nov. 11, features about 540 passenger and commercial vehicles, as well as motorcycles, from 58 companies. They include 77 vehicles making world premiers and 103 making Japan premiers. (Kyodo)
                      6 of 9 major life insurers see core profits expand in FY 2006

                      6 of 9 major life insurers see core profits expand in FY 2006

                      TOKYO, Japan - Nippon Life Insurance Co. Executive Director Yoshinobu Tsutsui speaks on the company's financial results for fiscal 2006 at a press conference in Tokyo on May 30. Six of Japan's nine major life insurers saw their core operating profits expand in the business year ended March 31 from a year earlier, supported by improved conditions for their fund management following interest rate hikes by the Bank of Japan. (Kyodo)